Ozmosis - Trusted Environment for Physicians

Physicians now have a "trusted environment" where they learn the way they learn best - from each other - with launch of Ozmosis, a verified, physicians-only online information exchange dedicated to the discovery and sharing of medical knowledge and the improvement of patient care.

"The strength of Ozmosis rests in the trusted connections it creates among physicians and the collective knowledge it provides back to physicians from the clinical insights and practice experiences they share," says Jason Bhan, M.D., co-founder of Ozmosis and a practicing, board certified family physician and clinical professor.

The Ozmosis Knowledge Exchange engenders trust by verifying the identity of its members before granting access to the site. Physicians on Ozmosis are clearly identified and not anonymous. Ozmosis provides detailed physician profiles and tools that allow members to always recognize the trusted colleagues they are learning from and communicating with.

"On Ozmosis, physicians are far more likely to apply the knowledge they acquire because they know and trust the source of the information," says Dr. Bhan.

Physicians can easily use tools on Ozmosis to bookmark and post content - journal abstracts, medical cases, videos, podcasts, blog entries, and clinical studies - from anywhere on the Web. Ozmosis then combines individual physician insights into a searchable knowledge repository that is updated in real-time.

"Ozmosis delivers an intelligent solution that senses the 'pulse' of the community and pushes critical insights to the surface for our physicians to see," says Joel Selzer, M.B.A., co-founder of Ozmosis. "In addition, Ozmosis provides an innovative search interface and personalized alerts that present relevant information back to our members based on their individual wants and needs."

By creating a new model for medical knowledge exchange, physicians are now sharing insights, experiences and evidence in a trusted and secure environment. For example, physicians on Ozmosis are discussing a multitude of issues, including the potential risks of influenza post-exposure prophylaxis and novel approaches for treating debilitating conditions such as chronic headaches and myofascial pain syndrome.

"Unlike other physician sites, Ozmosis creates a sanctuary free from outside interests where physicians can consult and learn from each other, unencumbered, saving valuable time and improving patient care," says Gary Klein, M.D., M.P.H., M.B.A., President Elect of the American Academy of Disaster Medicine, member of the Ozmosis Medical Advisory Board, and a recognized healthcare informatics expert. "Every time I log in, I am energized. I learn, I teach; this is how medicine is supposed to be."

In keeping with its mission to benefit physicians and improve patient care, Ozmosis delivers a unique business model that enables physicians to discover new products and services. Instead of traditional online advertising, physicians can choose to learn about healthcare products and services from other physicians. Ozmosis maintains a strict privacy policy, and product discovery areas are "opt-in" for physicians.

"Physicians on Ozmosis can discover and learn about innovative products such as mobile charge capture solutions or medical devices directly from their peers. When I am evaluating products and services for my practice and my students, I am far more interested in advice from my colleagues who have used these items in practice," says Scott Strayer, M.D., M.P.H., Associate Professor of Family Medicine and Public Health Services, University of Virginia, and founder and CEO of PocketMed, developer of the PocketBilling mobile charge capture solution.

For further information, please visit:
http://www.ozmosis.com

About Ozmosis
Ozmosis, an online Medical Knowledge Exchange, has been working with physicians to improve patient care since 2006. Ozmosis aggregates the collective wisdom and experience of its physicians and transforms individual insights into trusted knowledge for its members, providing physicians a place where they can turn daily for trusted and reliable clinical, practice management and health policy information. Offered at no cost for verified physicians, Ozmosis accelerates learning and knowledge exchange across medicine and is dedicated to improving collaboration in healthcare.

Most Popular Now

Pfizer to provide U.S. government with 10 million …

Pfizer Inc. (NYSE: PFE) today announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candid...

GSK and Vir Biotechnology announce United States g…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) announced US government contracts totalling approximately $1 billion[1] (USD) to purchase so...

Primary endpoint met in COMET-TAIL Phase III trial…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase...

Two billion doses of AstraZeneca’s COVID-19 vaccin…

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the l...

Merck and Ridgeback's molnupiravir, an oral COVID-…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Medicines and Healthcare products Re...

Johnson & Johnson COVID-19 vaccine named one o…

The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & ...

New target for COVID-19 vaccines identified

Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, c...

Repurposing a familiar drug for COVID-19

For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day...

Safety concerns raised for neuroblastoma candidate…

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Th...

Pfizer and BioNTech receive expanded U.S. FDA emer…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a ...

'Dancing molecules' successfully repair severe spi…

Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal ...

A target for potential cancer drugs may, in fact, …

In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyro...